StockData
PetVivo Holdings, Inc. logo

PetVivo Holdings, Inc. (PETV) stock

PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $27.79MP/E –Yield –

PetVivo r&d expenses

Research and development expenses are spending on new products and technology.

PetVivo's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.31M, down 14.9% year over year. For fiscal 2026 it was $1.42M, down 10.6% from the year before. Over ten years it grew 23.7% a year on average. The highest annual figure on record is $1.58M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Mar 31, 2026$1.42M-10.6%
FY2025Mar 31, 2025$1.58M+13.5%
FY2024Mar 31, 2024$1.40M+40.0%
FY2023Mar 31, 2023$996.36K+109.8%
FY2022Mar 31, 2022$474.88K+383.4%
FY2021Mar 31, 2021$98.23K+675.2%
FY2020Mar 31, 2020$12.67K-93.7%
FY2019Mar 31, 2019$200.98K+69.0%
FY2018Mar 31, 2018$118.94K-29.2%
FY2017Mar 31, 2017$167.89K-0.4%
FY2016Mar 31, 2016$168.60K+3735.3%
FY2015Mar 31, 2015$4.40K–
FY2012Mar 31, 2012$0-100.0%
FY2011Mar 31, 2011$157.30K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$233.42K-31.5%
Q4 FY2026CQ1 2026Mar 31, 2026$490.10K+36.7%
Q3 FY2026CQ4 2025Dec 31, 2025$322.99K-13.2%
Q2 FY2026CQ3 2025Sep 30, 2025$261.43K-43.8%
Q1 FY2026CQ2 2025Jun 30, 2025$340.51K-12.1%
Q4 FY2025CQ1 2025Mar 31, 2025$358.61K-8.2%
Q3 FY2025CQ4 2024Dec 31, 2024$371.95K+5.8%
Q2 FY2025CQ3 2024Sep 30, 2024$465.17K+29.5%
Q1 FY2025CQ2 2024Jun 30, 2024$387.52K+31.9%
Q4 FY2024CQ1 2024Mar 31, 2024$390.59K-27.2%
Q3 FY2024CQ4 2023Dec 31, 2023$351.58K+41.7%
Q2 FY2024CQ3 2023Sep 30, 2023$359.33K+156.0%
Q1 FY2024CQ2 2023Jun 30, 2023$293.77K+310.0%
Q4 FY2023CQ1 2023Mar 31, 2023$536.16K+186.4%
Q3 FY2023CQ4 2022Dec 31, 2022$248.16K+622.9%
Q2 FY2023CQ3 2022Sep 30, 2022$140.38K+20.6%
Q1 FY2023CQ2 2022Jun 30, 2022$71.66K-47.7%
Q4 FY2022CQ1 2022Mar 31, 2022$187.24K+175.5%
Q3 FY2022CQ4 2021Dec 31, 2021$34.33K+13.4%
Q2 FY2022CQ3 2021Sep 30, 2021$116.38K+14975.1%
Q1 FY2022CQ2 2021Jun 30, 2021$136.94K+2772.0%
Q4 FY2021CQ1 2021Mar 31, 2021$67.97K+853.0%
Q3 FY2021CQ4 2020Dec 31, 2020$30.27K-55.0%
Q4 FY2020CQ1 2020Mar 31, 2020$772-98.6%
Q3 FY2020CQ4 2019Dec 31, 2019$4.77K-93.9%
Q2 FY2020CQ3 2019Sep 30, 2019$7.13K-87.3%
Q4 FY2019CQ1 2019Mar 31, 2019$67.19K+303.3%
Q3 FY2019CQ4 2018Dec 31, 2018$55.92K+150.8%
Q2 FY2019CQ3 2018Sep 30, 2018$77.87K+226.3%
Q4 FY2018CQ1 2018Mar 31, 2018$56.12K+10.8%
Q3 FY2018CQ4 2017Dec 31, 2017$16.66K-60.5%
Q2 FY2018CQ3 2017Sep 30, 2017$22.29K-67.9%
Q1 FY2018CQ2 2017Jun 30, 2017$23.87K–
Q4 FY2017CQ1 2017Mar 31, 2017$50.66K–
Q3 FY2017CQ4 2016Dec 31, 2016$42.19K–
Q2 FY2017CQ3 2016Sep 30, 2016$69.55K–

More PetVivo figures

See a number that looks wrong?